chr14-28767524-C-A
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BA1BP4BP5_StrongBS2
This summary comes from the ClinGen Evidence Repository: The highest population minor allele frequency of the p.Pro82Gln variant in FOXG1 in gnomAD v2.1.1 is 0.00087 in the African/African American population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.0003) for BA1, and therefore meets this criterion (BA1). The p.Pro82Gln variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2). The p.Pro82Gln variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx) (BP5_Strong). Computational analysis prediction tools suggest that the p.Pro82Gln variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Pro82Gln variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BS2, BP5_Strong, BP4). (FOXG1 specification v.3; approved on 8/30/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA314578/MONDO:0100040/035
Frequency
Consequence
NM_005249.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXG1 | NM_005249.5 | c.245C>A | p.Pro82Gln | missense_variant | 1/1 | ENST00000313071.7 | NP_005240.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXG1 | ENST00000313071.7 | c.245C>A | p.Pro82Gln | missense_variant | 1/1 | NM_005249.5 | ENSP00000339004 | P1 | ||
FOXG1 | ENST00000706482.1 | c.245C>A | p.Pro82Gln | missense_variant | 2/2 | ENSP00000516406 | P1 | |||
LINC01551 | ENST00000675861.1 | n.374+1511C>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000265 AC: 39AN: 147052Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000221 AC: 20AN: 904362Hom.: 0 Cov.: 17 AF XY: 0.0000282 AC XY: 12AN XY: 425954
GnomAD4 genome AF: 0.000265 AC: 39AN: 147154Hom.: 0 Cov.: 31 AF XY: 0.000251 AC XY: 18AN XY: 71630
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 23, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 14, 2016 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 08, 2019 | - - |
Rett syndrome, congenital variant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at